STOCK TITAN

TFA THERAPEUTICS INC (RAJAF) Net Income by Year

RAJAF

TFA THERAPEUTICS INC reported a net loss of $155K in fiscal year 2025. This represents an increase of 31.6% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters TFA THERAPEUTICS INC has filed alongside them.

FY2025 annual
Net Income -$155K
YoY +31.6%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RAJAF Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-F/AFY2110-K
Net Income-$155K+31.6%-$226K-130.1%$752K+204.4%-$720K-46.7%-$491K

RAJAF Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-F/AQ3'2310-QQ4'2220-F/AQ4'2110-KQ4'2010-K
Net IncomeN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More TFA THERAPEUTICS INC financials

Frequently Asked Questions

What was TFA THERAPEUTICS INC's net income in fiscal year 2025?

TFA THERAPEUTICS INC reported a net loss of $155K in fiscal year 2025.

How fast is TFA THERAPEUTICS INC's net income growing?

TFA THERAPEUTICS INC (RAJAF) net income rose by 31.6% year over year, from -$226K to -$155K in fiscal year 2025.

How has TFA THERAPEUTICS INC's net income changed over the years?

Across the 5 fiscal years this page covers, TFA THERAPEUTICS INC (RAJAF) net income went from -$491K in fiscal year 2021 to -$155K in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what TFA THERAPEUTICS INC (RAJAF) reported on that line in every period on record.